| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/02/1994 | EP0246307B1 Cys codon-modified dna |
| 02/01/1994 | US5283353 Enzymeric cleavage from glycoprotein |
| 02/01/1994 | US5283342 Complexes to enhance delivery of tumor drugs |
| 02/01/1994 | US5283323 Complexing antigen to immunoglobulin; sensitivity at low dosage |
| 02/01/1994 | US5283317 Water soluble adduct of superoxide dismutase |
| 02/01/1994 | US5283185 Mixing aqueous dispersion of cationic lipid and co-lipid with nucleic acids to form complex, incubating cells with complex |
| 02/01/1994 | CA2101496A1 Base for transdermal administration |
| 01/31/1994 | CA2100600A1 New carbohydrate-based anti-inflammatory agents |
| 01/30/1994 | CA2101008A1 Bioadhesive treatment compositions and method of use |
| 01/27/1994 | DE4224401A1 New biodegradable homo- and co-polymer(s) for pharmaceutical use - produced by polycondensation of prod. from heterolytic cleavage of aliphatic polyester with functionalised (cyclo)aliphatic cpd. |
| 01/26/1994 | EP0580171A2 Pharmaceutical composition containing a carrier bound antitumor substance |
| 01/26/1994 | EP0580078A1 Hydrophilic groups containing poly(vinylamine) derivatives, process for their manufacture and use thereof as pharmaceutical compounds, substrates for active substances and foodstuff ingredients |
| 01/26/1994 | EP0580074A1 Stable preparation containing azelastine hydrochloride |
| 01/26/1994 | EP0579996A1 Inclusion compounds of 5,10-methylenetetrahydrofolic acid and cyclodextrin |
| 01/26/1994 | EP0579958A1 A preventive or therapeutic medicine for pancreatitis |
| 01/26/1994 | EP0579703A1 Inhibition of aggregation of drug containing particles. |
| 01/26/1994 | EP0500658B1 A nicotine containing stimulant unit |
| 01/25/1994 | US5281662 Anthraquinone dye treated materials |
| 01/25/1994 | US5281580 Respiratory system disorders |
| 01/25/1994 | US5281421 Tablet comprising gemfibrozil and surfactant having HLB value of 10 to 50 |
| 01/25/1994 | US5281420 Solid dispersion compositions of tebufelone |
| 01/25/1994 | CA2063576C Slow release vehicles for minimizing skin irritancy of topical compositions |
| 01/25/1994 | CA1326453C Pharmaceutical composition containing pentamidine |
| 01/25/1994 | CA1326452C Ifosfamide-mesna lyochilizati and process for producing same |
| 01/25/1994 | CA1326448C Steroid ointment formulation |
| 01/25/1994 | CA1326447C Steroid cream formulation |
| 01/25/1994 | CA1326439C Parenteral growth hormone formulations |
| 01/25/1994 | CA1326438C Sustained and controlled release of water insoluble polypeptides |
| 01/24/1994 | CA2100818A1 Pharmaceutical composition |
| 01/23/1994 | CA2101011A1 Polyvinylamine derivatives having hydrophilic centers, processes for their preparation and the use of the compounds as a medicament, active compound carrier and foodstuff auxiliary |
| 01/20/1994 | WO1994001483A1 Biocompatible polymer conjugates |
| 01/20/1994 | WO1994001460A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 01/20/1994 | WO1994001448A1 Oligonucleotides modified with conjugate groups |
| 01/20/1994 | WO1994001139A1 Targeting somatic gene therapy to joints |
| 01/20/1994 | WO1994001138A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 01/20/1994 | WO1994001137A1 Method for delivery of cytotoxic agents and components thereof |
| 01/20/1994 | WO1994001136A1 A drug delivery device and a method of making such device |
| 01/20/1994 | WO1994001118A1 Methods for enhancing drug delivery with modified saponins |
| 01/20/1994 | WO1994001100A1 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/20/1994 | WO1994001099A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| 01/20/1994 | WO1994001092A1 Composition for controlled release of an active substance and method for the preparation of such a composition |
| 01/20/1994 | WO1994001091A1 Composition for controlled release of an active substance and method for the preparation of such a composition |
| 01/20/1994 | WO1994001090A1 Solid and liquid solutions of drugs which are not readily soluble in water |
| 01/20/1994 | WO1994001089A1 Liposomes, method of preparing them and their use in the preparation of drugs |
| 01/20/1994 | WO1994001087A1 Precipitation of one or more active compounds in situ |
| 01/20/1994 | WO1994001074A1 Composition for dermatologic preparation |
| 01/20/1994 | WO1994001073A1 Cosmetic composition in the form of a gelled silicone/water triple water/oil emulsion |
| 01/20/1994 | CA2139853A1 Cosmetic composition in the form of a gelled silicone/water triple water/oil emulsion |
| 01/20/1994 | CA2139747A1 A drug delivery device and a method of making such device |
| 01/20/1994 | CA2139494A1 Composition for controlled release of an active substance and method for the preparation of such a composition |
| 01/20/1994 | CA2139493A1 Composition for controlled release of an active substance and method for the preparation of such a composition |
| 01/20/1994 | CA2139437A1 Methods for enhancing drug delivery with modified saponins |
| 01/19/1994 | EP0579435A1 Cyclodextrin complexation |
| 01/19/1994 | EP0579159A2 Method for preparing mixtures of polyglycerol fatty acid esters and their application in cosmetic, pharmaceutical and chemical-technical compositions |
| 01/19/1994 | EP0579155A2 Aqueous preparation of arulene sodium sulfonate |
| 01/19/1994 | EP0578780A1 Suppression of thromboxane levels by percutaneous administration of aspirin |
| 01/19/1994 | EP0578774A1 Monoclonal antibodies to stem cell factor receptors |
| 01/19/1994 | EP0578768A1 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress. |
| 01/19/1994 | EP0578765A1 Delivery of x-ray contrast agents using receptor mediated endocytosis |
| 01/19/1994 | EP0578732A1 Chewable antacid compositions. |
| 01/19/1994 | EP0578726A1 Virus inactivation method and pharmaceutical composition therefor. |
| 01/19/1994 | EP0323494B1 Lecithin gel |
| 01/19/1994 | EP0267277B1 Compositions comprising 1-substituted lactams |
| 01/19/1994 | CN1080869A Method for preparing inhalation of oenothera odorata oil |
| 01/19/1994 | CN1080846A Compressed gas packagings using polyoxyethylene glyleryl oleates description |
| 01/19/1994 | CN1080845A Poultry color-coded inactivated vaccines |
| 01/18/1994 | US5280113 Method for producing synthetic N-linked glycoconjugates |
| 01/18/1994 | US5280018 Vehicle for optical application of pharmaceuticals |
| 01/18/1994 | US5279835 Compression molding with water soluble material such as sorbitol, mannitol and sodium chloride |
| 01/18/1994 | CA1326211C Antibiotic solutions and the lyophilization thereof |
| 01/18/1994 | CA1326210C Nasal formulations and a process for preparation thereof |
| 01/12/1994 | EP0578620A1 Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues |
| 01/12/1994 | EP0578293A1 E-coli P-fimbrine as immunogenic carrier system against GnRH |
| 01/12/1994 | EP0578231A1 Inclusion complexes of clavulanic acid and of alkali salts thereof with beta-cyclodextrines |
| 01/12/1994 | EP0577817A1 Water-in-oil emulsion stable in the course of time, with high silicone content. |
| 01/12/1994 | EP0577725A1 Targeted drug delivery via mixed phosphate derivatives |
| 01/12/1994 | EP0577659A1 Cross-linking agent. |
| 01/12/1994 | EP0577648A1 Novel protein polycation conjugates |
| 01/12/1994 | EP0577646A1 Sustained release drug delivery devices |
| 01/12/1994 | EP0577612A1 Immunotoxin from anti-cd5 monoclonal antibodies |
| 01/12/1994 | EP0577602A1 Transdermal contraceptive formulations, methods and devices |
| 01/12/1994 | EP0494910B1 Eye-drops |
| 01/12/1994 | EP0438531B1 Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same |
| 01/12/1994 | EP0423228B1 Immunoconjugates for cancer diagnosis and therapy |
| 01/12/1994 | EP0382716B1 Use of commercial lecithin as skin penetration enhancer |
| 01/12/1994 | CN1080658A 蛋白质c衍生物 C protein derivative |
| 01/12/1994 | CN1080546A Carrier for nose dropping medicine |
| 01/12/1994 | CN1080523A Nasal cavity medicine and preparing process |
| 01/11/1994 | US5278202 Polymers biodegradable by enzyme hydrolysis |
| 01/11/1994 | US5278201 Polymers biodegradable by enzyme hydrolysis |
| 01/11/1994 | US5278172 Method and composition for treating tendon or joint inflammation using a vasodilator |
| 01/11/1994 | US5277914 Preparation of liposome and lipid complex compositions |
| 01/11/1994 | US5277913 Liposomal delivery system with photoactivatable triggered release |
| 01/11/1994 | US5277911 Thermal reversible aqueous gel |
| 01/11/1994 | US5277894 Method for tumor detection and treatment |
| 01/11/1994 | CA1325976C Azelastine-containing medicaments with controlled release of the active substance |
| 01/11/1994 | CA1325973C Cyclosporin-containing pharmaceutical composition |
| 01/11/1994 | CA1325970C Resinous composition capable of releasing a bioactive substance at a controlled rate |
| 01/11/1994 | CA1325918C Flavour compositions, flavoured foodstuffs and stimulants containing one or more alkyl (3-methylthio)-butrates as flavour components |
| 01/09/1994 | CA2100045A1 Inclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic .beta. - cyclodextrin derivatives, a proce ss for the preparation thereof and the use thereof |